| Hydroxyurea in Young Children With Sickle Cell Anemia (NCT00519701) | Duke University | 2002-04-01 |
| A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia. (NCT00040677) | Icagen | 2002-02-01 |
| Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension (NCT00023296) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-07-27 |
| Nitric Oxide to Improve Blood Flow in Sickle Cell Disease (NCT00009581) | National Institutes of Health Clinical Center (CC) | 2001-01-01 |
| Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies (NCT00040469) | Baylor College of Medicine | 2000-08-01 |
| Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies (NCT00040417) | Baylor College of Medicine | 2000-08-01 |
| Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders (NCT00005893) | Fairview University Medical Center | 2000-06-01 |
| A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders (NCT00005783) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-03-01 |
| Bone Marrow Transplantation in Treating Children With Sickle Cell Disease (NCT00004485) | Fred Hutchinson Cancer Center | 1999-12-01 |
| Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia (NCT00004492) | University of North Carolina | 1999-10-01 |
| Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes (NCT00004143) | David Rizzieri, MD | 1999-09-01 |
| Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease (NCT00006130) | UCSF Benioff Children's Hospital Oakland | 1999-06-01 |
| Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia (NCT00001716) | National Institutes of Health Clinical Center (CC) | 1998-07-01 |
| Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease (NCT00004408) | Mast Therapeutics, Inc. | 1997-11-01 |
| Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers (NCT00004412) | Susan P. Perrine | 1997-09-01 |
| Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes (NCT00004404) | Boston Children's Hospital | 1997-04-01 |
| Pilot Study of Fructose for Sickle Cell Crisis (NCT00004797) | National Center for Research Resources (NCRR) | 1995-08-01 |
| Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis (NCT00578435) | Memorial Sloan Kettering Cancer Center | 1994-01-01 |
| Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia (NCT00001197) | National Heart, Lung, and Blood Institute (NHLBI) | 1984-02-07 |
| Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-Thalassemia (NCT01092169) | Hillel Yaffe Medical Center | |